Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - HALE DAVID F
Last Updated 
26-Nov-09
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

HALE DAVID F: Declared Holdings
Company/RelationshipReportedShares  Ownership
Metabasis Therapeutics, Inc
Director
NasdaqCM:MBRX
(historical quotes, profile, other insiders)
16-Apr-0860,337  Indirect
Somaxon Pharmaceuticals, Inc.
Director
NasdaqCM:SOMX
(historical quotes, profile, other insiders)
30-Sep-09
30-Jun-09
11,449
   235,430
246,879
  Direct
  Indirect  
  Total

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
30-Sep-09 11,449SOMX Acquisition (Non Open Market) at $0 per share.
30-Jun-09 *12,030SOMX Acquisition (Non Open Market) at $0 per share.
29-May-09 18,149SOMX Acquisition (Non Open Market) at $0 per share.
30-Apr-09 39,780SOMX Acquisition (Non Open Market) at $0 per share.
31-Mar-09 41,484SOMX Acquisition (Non Open Market) at $0 per share.
28-Feb-09 33,074SOMX Acquisition (Non Open Market) at $0 per share.
17-Feb-09 27,523SOMX Acquisition (Non Open Market) at $0 per share.
31-Jan-09 5,890SOMX Acquisition (Non Open Market) at $0 per share.
28-Nov-08 37,500SOMX Acquisition (Non Open Market) at $0 per share.
16-Apr-08 *3,111MBRX Option Exercise at $2.34 per share.
(Cost of $7,279)
16-Apr-08 *10,000MBRX Purchase at $2.34 per share.
(Cost of $23,400)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?